Cyclacel Pharmaceuticals Inc (CYCC) — Defensive Interval Ratio
Cyclacel Pharmaceuticals Inc (CYCC) has a Defensive Interval Ratio of 24013 days as of June 2025. Defensive assets of $50.00K (cash $-, short-term investments $-, receivables $50.00K) cover 24013 days of daily cash needs of $2.08/day. Check Cyclacel Pharmaceuticals Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Cyclacel Pharmaceuticals Inc Defensive Interval Ratio (2003–2024)
This chart shows how Cyclacel Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 21 annual periods from 2003 to 2024. As of June 2025, the ratio stands at 24013 days, meaning defensive assets of $50.00K can fund 24013 days of operations without new revenue. Also explore Cyclacel Pharmaceuticals Inc (CYCC) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Cyclacel Pharmaceuticals Inc (2003–2024)
The table below presents the year-by-year Defensive Interval Ratio for Cyclacel Pharmaceuticals Inc from 2003 to 2024, covering 21 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CYCC stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 14 days | $237.00K | $17.17K/day | $- | $- | ▼ -117 days |
| 2023 | 131 days | $2.93 Million | $22.36K/day | $- | $- | ▼ -95 days |
| 2022 | 227 days | $4.66 Million | $20.58K/day | $- | $- | ▼ -25 days |
| 2021 | 251 days | $3.73 Million | $14.83K/day | $- | $- | ▲ +59 days |
| 2020 | 193 days | $1.31 Million | $6.81K/day | $- | $- | ▼ -7 days |
| 2019 | 200 days | $1.33 Million | $6.63K/day | $- | $- | ▲ +71 days |
| 2018 | 129 days | $1.57 Million | $12.19K/day | $- | $66.00K | ▼ -15 days |
| 2017 | 144 days | $1.62 Million | $11.27K/day | $- | $132.00K | ▼ -8 days |
| 2016 | 152 days | $2.19 Million | $14.41K/day | $- | $132.00K | ▲ +102 days |
| 2015 | 50 days | $784.00K | $15.76K/day | $- | $132.00K | ▲ +30 days |
| 2014 | 19 days | $400.00K | $20.53K/day | $- | $132.00K | ▼ -4 days |
| 2013 | 24 days | $489.00K | $20.54K/day | $- | $132.00K | ▼ -23 days |
| 2012 | 46 days | $1.19 Million | $25.58K/day | $- | $153.00K | ▼ -1101 days |
| 2011 | 1148 days | $20.43 Million | $17.80K/day | $- | $19.89 Million | ▼ -476 days |
| 2010 | 1623 days | $29.07 Million | $17.90K/day | $- | $29.07 Million | ▲ +1560 days |
| 2008 | 64 days | $1.50 Million | $23.64K/day | $- | $1.50 Million | ▼ -687 days |
| 2007 | 750 days | $30.23 Million | $40.31K/day | $- | $27.77 Million | ▲ +186 days |
| 2006 | 564 days | $12.25 Million | $21.70K/day | $- | $9.76 Million | ▼ -183 days |
| 2005 | 748 days | $10.69 Million | $14.30K/day | $- | $10.69 Million | ▼ -898 days |
| 2004 | 1646 days | $33.42 Million | $20.31K/day | $- | $33.42 Million | ▲ +1365 days |
| 2003 | 280 days | $11.30 Million | $40.31K/day | $- | $11.30 Million | — |